F230. COMPARISON OF PALIPERIDONE PALMITATE 3-MONTH AND PALIPERIDONE PALMITATE 1-MONTH FORMULATION FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A PHASE 3 NON-INFERIORITY STUDY

BACKGROUND: Negative symptoms of schizophrenia are key predictors of long-term disability. It is important to understand whether treatment with long-acting injectable antipsychotics can improve negative symptom psychopathology. Paliperidone palmitate 3-month formulation (PP3M) provides a sustained r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Schizophr Bull
Egile Nagusiak: Mathews, Maju, Gopal, Srihari, Singh, Arun, Gogate, Jagadish, Kim, Edward, Pungor, Katalin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5888232/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby017.761
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak